ArticleFrontiers in digital health2026
Perspectives on digital therapeutic prescribing: a qualitative study among German psychological psychotherapists.
Article in Frontiers in digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Since 2020, psychological psychotherapists in Germany can issue CE-certified prescription digital therapeutics (German Methods: A qualitative study design was used to explore prior knowledge of, experience with, and attitudes toward prescribing DiGA, as well as information needs and wishes. Two researchers conducted semi-structured interviews in July and August 2024 with 13 licensed German psychological psychotherapists. Audio recordings of the interviews were transcribed verbatim and analyzed using deductive and inductive coding according to qualitative content analysis. Results: Psychotherapists indicated moderate knowledge about DiGA, primarily gained through professional exchanges and driven by personal interest. While psychotherapists differed in their experience with prescribing DiGA, the reported need for more information on several aspects was a shared matter. Regarding the attitudes toward prescribing DiGA, perceived advantages included bridging waiting times, enhancing therapy support, and improving aftercare. Subjective barriers included a lack of established prescribing routines (unlike physicians) or skepticism about managing patients' crises effectively while using DiGA. Wishes pertaining to the informational content of DiGA included an evidence base, data privacy, or prescription guidelines. Psychotherapists varied broadly in their preferred methods of information delivery (e.g., in sources such as collegial exchange or media channels, such as online workshops). Discussion: The findings indicate that despite a positive mindset toward DiGA, the absence of routine practice hinders its widespread adoption among psychotherapists in Germany. Increasing knowledge about DiGA may lead to greater adoption of prescribing. This qualitative formative research will form the basis for further research to evaluate and optimize information strategies regarding digital therapeutics. Future research should focus on the influence of tailored information on actual prescriptions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.